BAIMA POMA, CINZIA
BAIMA POMA, CINZIA
Impact of cancer in the management of delivery: 10 years of variations
2018-01-01 Masturzo B.; Parpinel G.; Macchi C.; De Ruvo D.; Paracchini S.; Baima Poma C.; Danna P.; Pagliardini G.; Zola P.
Malattie del Gestotrofoblasto Cap.28
2011-01-01 Zola P; Zanfagnin V; Tripodi E; Baima Poma C.
Monitoring chemotherapy cardiotoxicity: how evaluate it?
2012-01-01 Modaffari P; Piovano E; Parrini I; MR Conte; Vignati C; Perotto S; Baima Poma C; Ferrero A
Phase I/II study with pegylated liposomal doxorubicin and prolonged infusion gemcitabine in recurrent ovarian cancer
2009-01-01 Ferrero A; Baima Poma C; Cattel L; Piovano E; Perotto S; Modaffari P; Dompè D; Zola P
Retrospective evaluation of follow up procedures in endometrial cancer: background of ongoing TOTEM RCT
2009-01-01 E.Piovano; G.Ciccone; L.Fuso; S.Mazzola; S.Perotto; C.Baima Poma; P.Modaffari and P.Zola
Searching predictive factors of hypersensitivity reaction to taxanes and platinum salts in gynecologic pelvic neoplasms chemotherapy
2009-01-01 Piovano E; Pivetta E; Modaffari P; Martra F; Baima Poma C; Perotto S; Dompè D and Ferrero AM
The ADNEX model to triage adnexal masses: An external validation study and comparison with the IOTA two-step strategy and subjective assessment by an experienced ultrasound operator
2020-01-01 Viora E.; Piovano E.; Baima Poma C.; Cotrino I.; Castiglione A.; Cavallero C.; Sciarrone A.; Bastonero S.; Iskra L.; Zola P.
Treatment of early cervical cancer:survival, complications and economical aspects
2012-01-01 P.Zola;E.Tripodi;V.Zanfagnin;C.Baima Poma;S.Perotto;P.Modaffari;F.Martra;L.Fuso
Ultrasound and clinical characteristics of uterine smooth muscle tumors of uncertain malignant potential (STUMPs)
2020-01-01 Cotrino I.; Carosso A.; Macchi C.; Baima Poma C.; Cosma S.; Ribotta M.; Viora E.; Sciarrone A.; Borella F.; Zola P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of cancer in the management of delivery: 10 years of variations | 2018 | Masturzo B.; Parpinel G.; Macchi C.; De Ruvo D.; Paracchini S.; Baima Poma C.; Danna P.; Pagliardini G.; Zola P. | |
| Malattie del Gestotrofoblasto Cap.28 | 2011 | Zola P; Zanfagnin V; Tripodi E; Baima Poma C. | |
| Monitoring chemotherapy cardiotoxicity: how evaluate it? | 2012 | Modaffari P; Piovano E; Parrini I; MR Conte; Vignati C; Perotto S; Baima Poma C; Ferrero A | |
| Phase I/II study with pegylated liposomal doxorubicin and prolonged infusion gemcitabine in recurrent ovarian cancer | 2009 | Ferrero A; Baima Poma C; Cattel L; Piovano E; Perotto S; Modaffari P; Dompè D; Zola P | |
| Retrospective evaluation of follow up procedures in endometrial cancer: background of ongoing TOTEM RCT | 2009 | E.Piovano; G.Ciccone; L.Fuso; S.Mazzola; S.Perotto; C.Baima Poma; P.Modaffari and P.Zola | |
| Searching predictive factors of hypersensitivity reaction to taxanes and platinum salts in gynecologic pelvic neoplasms chemotherapy | 2009 | Piovano E; Pivetta E; Modaffari P; Martra F; Baima Poma C; Perotto S; Dompè D and Ferrero AM | |
| The ADNEX model to triage adnexal masses: An external validation study and comparison with the IOTA two-step strategy and subjective assessment by an experienced ultrasound operator | 2020 | Viora E.; Piovano E.; Baima Poma C.; Cotrino I.; Castiglione A.; Cavallero C.; Sciarrone A.; Bastonero S.; Iskra L.; Zola P. | |
| Treatment of early cervical cancer:survival, complications and economical aspects | 2012 | P.Zola;E.Tripodi;V.Zanfagnin;C.Baima Poma;S.Perotto;P.Modaffari;F.Martra;L.Fuso | |
| Ultrasound and clinical characteristics of uterine smooth muscle tumors of uncertain malignant potential (STUMPs) | 2020 | Cotrino I.; Carosso A.; Macchi C.; Baima Poma C.; Cosma S.; Ribotta M.; Viora E.; Sciarrone A.; Borella F.; Zola P. |